Christophers E, Schmidt B
Arch Dermatol Res. 1982;272(3-4):245-50. doi: 10.1007/BF00509052.
8-methoxypsoralen (8-MOP) and 3-Carbethoxypsoralen (3-CPs) are known photoreagents which have been employed in the treatment of psoriasis. Using skin fibroblasts grown in vitro we have determined the action spectra of both compounds in the long ultraviolet range. Narrow-band interference filters were applied to a Xenon lamp. Reduction in methyl-3H-thymidine (3H-TdR) uptake served as a parameter for photoinhibited cells. The results show a linear increate of 8-MOP-mediated photoinhibition with increasing wavelengths; 3-CPs showed comparatively weak inhibitory rates at the lower wavelength range (349-365 nm). Possibly this is due to the formation of 3-CPs photoproducts which are unreactive with DNA. Compared to 8-MOP, the monofunctional photoreagent 3-CPs is a weak photoinhibitor.
8-甲氧基补骨脂素(8-MOP)和3-乙氧羰基补骨脂素(3-CPs)是已知的光试剂,已用于银屑病的治疗。利用体外培养的皮肤成纤维细胞,我们测定了这两种化合物在长紫外波段的作用光谱。将窄带干涉滤光片应用于氙灯。甲基-3H-胸腺嘧啶核苷(3H-TdR)摄取量的减少作为光抑制细胞的一个参数。结果表明,8-MOP介导的光抑制作用随波长增加呈线性增加;3-CPs在较低波长范围(349-365nm)显示出相对较弱的抑制率。这可能是由于3-CPs光产物的形成,这些光产物与DNA无反应性。与8-MOP相比,单功能光试剂3-CPs是一种弱光抑制剂。